{\rtf1\ansi\ansicpg1252\cocoartf2821
\cocoatextscaling0\cocoaplatform0{\fonttbl\f0\fswiss\fcharset0 Helvetica;}
{\colortbl;\red255\green255\blue255;}
{\*\expandedcolortbl;;}
\margl1440\margr1440\vieww11520\viewh8400\viewkind0
\pard\tx720\tx1440\tx2160\tx2880\tx3600\tx4320\tx5040\tx5760\tx6480\tx7200\tx7920\tx8640\pardirnatural\partightenfactor0

\f0\fs24 \cf0 \{\
  "Postsurgical Evaluation": \{\
    "No gross residual disease in neck": \{\
      "Action": "Consideration for Initial Postoperative RAI Therapy (ONC-3)"\
    \},\
    "Gross residual disease in neck": \{\
      "Diagnostic steps": [\
        "Cross-sectional CT or MRI of neck with contrast",\
        "FDG-PET/CT or FDG-PET/MRI"\
      ],\
      "If resectable": \{\
        "Action": "Resect, if possible",\
        "Result": \{\
          "No gross residual disease": \{\
            "Next": "Consideration for Initial Postoperative RAI Therapy (ONC-3)"\
          \},\
          "Gross residual disease": \{\
            "Evaluation": [\
              "TSH + Tg measurement + Tg ab (6\'9612 weeks postoperatively)",\
              "Iodine-123 or Iodine-131 total body radioiodine imaging (category 2B)"\
            ],\
            "Outcomes": \{\
              "RAI uptake absent": \{\
                "Action": [\
                  "Monitoring of residual disease",\
                  "Consider EBRT if disease is threatening vital structures"\
                ]\
              \},\
              "RAI uptake present or No RAI imaging performed": \{\
                "Action": [\
                  "RAI therapy (preferred)",\
                  "Consider EBRT if disease is threatening vital structures"\
                ]\
              \}\
            \}\
          \}\
        \}\
      \},\
      "If unresectable": \{\
        "Noninvasive and not metastatic": \{\
          "Evaluation": [\
            "TSH + Tg measurement + Tg ab (6\'9612 weeks postoperatively)",\
            "Iodine-123 or Iodine-131 total body radioiodine imaging (category 2B)"\
          ],\
          "Outcomes": \{\
            "RAI uptake present or No RAI imaging performed": "RAI therapy"\
          \}\
        \},\
        "Invasive or widely metastatic": \{\
          "Evaluation": [\
            "TSH + Tg measurement + Tg ab (6\'9612 weeks postoperatively)",\
            "Iodine-123 or Iodine-131 total body radioiodine imaging (category 2B)"\
          ],\
          "Outcomes": \{\
            "RAI uptake absent": "Treatment of Locally Recurrent, Advanced, and/or Metastatic Disease (ONC-9)",\
            "Heterogeneous uptake (some but not all known disease has iodine uptake)": [\
              "Treatment of Locally Recurrent, Advanced, and/or Metastatic Disease (ONC-9)",\
              "Consider RAI when majority of disease is RAI avid"\
            ]\
          \},\
          "Special consideration": "For locoregional invasive disease or rapid progression, consider EBRT, systemic therapy"\
        \}\
      \}\
    \}\
  \}\
\}\
}